AMED vs EHAB
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMED is a Sell and EHAB is a Sell.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMED’s FA Score shows that 0 FA rating(s) are green whileEHAB’s FA Score has 0 green FA rating(s).
- AMED’s FA Score: 0 green, 5 red.
- EHAB’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMED’s TA Score shows that 4 TA indicator(s) are bullish while EHAB’s TA Score has 3 bullish TA indicator(s).
- AMED’s TA Score: 4 bullish, 4 bearish.
- EHAB’s TA Score: 3 bullish, 7 bearish.
Price Growth
AMED (@Medical/Nursing Services) experienced а +0.66% price change this week, while EHAB (@Medical/Nursing Services) price change was +2.86% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.32%. For the same industry, the average monthly price growth was -2.31%, and the average quarterly price growth was +1651.64%.
Reported Earning Dates
AMED is expected to report earnings on Feb 19, 2025.
EHAB is expected to report earnings on Feb 12, 2025.
Industries' Descriptions
@Medical/Nursing Services (+0.32% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| AMED | EHAB | AMED / EHAB | |
| Capitalization | 3.02B | 566M | 533% |
| EBITDA | 129M | -16.5M | -782% |
| Gain YTD | -4.650 | -26.957 | 17% |
| P/E Ratio | 1170.50 | 10.75 | 10,886% |
| Revenue | 2.24B | 1.05B | 214% |
| Total Cash | 126M | 27.4M | 460% |
| Total Debt | 487M | 610M | 80% |
AMED | ||
|---|---|---|
OUTLOOK RATING 1..100 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 77 | |
PRICE GROWTH RATING 1..100 | 73 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AMED | EHAB | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 65% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 57% | 1 day ago 60% |
| Momentum ODDS (%) | 1 day ago 51% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 56% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 57% | 1 day ago 63% |
| TrendMonth ODDS (%) | 1 day ago 56% | 1 day ago 59% |
| Advances ODDS (%) | 1 day ago 60% | 1 day ago 68% |
| Declines ODDS (%) | 5 days ago 60% | 5 days ago 87% |
| BollingerBands ODDS (%) | 1 day ago 69% | 1 day ago 75% |
| Aroon ODDS (%) | N/A | 1 day ago 83% |
AMED and
Correlation & Price change
A.I.dvisor tells us that AMED and ENSG have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and ENSG's prices will move in lockstep.
| Ticker / NAME | Correlation To AMED | 1D Price Change % | ||
|---|---|---|---|---|
| AMED | 100% | +0.53% | ||
| ENSG - AMED | 25% Poorly correlated | -0.67% | ||
| TALK - AMED | 24% Poorly correlated | +4.23% | ||
| OPCH - AMED | 23% Poorly correlated | +2.85% | ||
| BKD - AMED | 22% Poorly correlated | +2.81% | ||
| EHAB - AMED | 21% Poorly correlated | +1.20% | ||
More | ||||
EHAB and
Correlation & Price change
A.I.dvisor tells us that EHAB and MD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EHAB and MD's prices will move in lockstep.
| Ticker / NAME | Correlation To EHAB | 1D Price Change % | ||
|---|---|---|---|---|
| EHAB | 100% | +1.20% | ||
| MD - EHAB | 31% Poorly correlated | +1.42% | ||
| USPH - EHAB | 31% Poorly correlated | +0.92% | ||
| BKD - EHAB | 31% Poorly correlated | +2.81% | ||
| SGRY - EHAB | 30% Poorly correlated | -1.46% | ||
| ADUS - EHAB | 29% Poorly correlated | +2.88% | ||
More | ||||